Troy E. Wilson - President and CEO, Director at Kura Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
KURA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Troy E. Wilson - trading volume in the past year for Kura Oncology, Inc.

Holdings reported by Troy E. Wilson for Kura Oncology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 429K $2.21M $8.94 Nov 13, 2025 Direct
Common Stock 300K $1.81M $6.02 Nov 13, 2025 by Lorax Charitable Remainder Unitrust
Common Stock 279K $1.68M $6.02 Nov 13, 2025 by One Fish Two Fish Revocable Trust
Option to purchase common stock 625K Jan 2, 2025 Direct Common Stock

Transactions reported by Troy E. Wilson for Kura Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.